Imbio adds analysis software to Nuance AI marketplace

By staff writers

July 10, 2020 -- Artificial intelligence (AI) software developer Imbio said that its chest CT image analysis software will be available on the Nuance AI Marketplace.

Imbio's Lung Density Analysis software, which has received U.S. Food and Drug Administration (FDA) clearance, quantifies lung regions with abnormal tissue density and generates visual maps of patients' lungs. Imbio's Lung Texture Analysis software for detecting texture abnormalities is currently pending FDA clearance, the firm said.

Copyright © 2020
Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking